CHA2DS2-VASC Score and this score components in predicting radial artery complications of among patients who underwent elective transradial coronary angiogram

Transradial approach (TRA) has been more and more accepted for cardiovascular operations. TRA uncommonly leads to hemorrhagic and vascular complications. CHA2DS2-VASc score is utilized to estimation the risk of thrombosis in patients with atrial fibrillation. We intended to assess the relationship between the CHA2DS2- VASc score or components of this score and radial artery complications after transradial coronary angiography. A total of 412 consecutive patients who underwent a TRA were evaluated in this study. Patients were divided into two groups as total complications (n= 73) and no-complications (n= 339) groups. The CHA2DS2-VASc score was higher in patients who had total complications group yet it was not statistically significant (p=.149). Total complication group were older compared to control group (p=.017). As the radial artery diameter decreased, and sheath/radial artery diameter increased, the risk of the total complication group higher significantly (for all; p

___

1. Feldman DN, RV Swaminathan, LA Kaltenbach, et al. Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention: an updated report from the national cardiovascular data registry (2007-2012). Circulation. 2013;127:2295-306.

2. Cooper CJ, RA El-Shiekh, DJ Cohen, et al. Effect of transradial access on quality of life and cost of cardiac catheterization: A randomized comparison. Am Heart J. 1999;138:430-6.

3. Spaulding C, T Lefevre, F Funck, et al. Left radial approach for coronary angiography: results of a prospective study. Cathet Cardiovasc Diagn.1996; 39:365-70.

4. Tatli E, A Buturak, A Cakar, et al. Unusual vascular complications associated with transradial coronary procedures among 10,324 patients: case based experience and treatment options. J Interv Cardiol. 2015;28:305-12.

5. Hirsh J, R Raschke. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:188-203.

6. Saliba W, N Gronich, O Barnett-Griness, et al. Usefulness of CHADS2 and CHA2DS2-VASc Scores in the prediction of new-onset atrial fibrillation: a population-based study. Am J Med. 2016;129:843-9.

7. Lip GYR. Nieuwlaat, R Pisters, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137:263-72.

8. Melgaard LA, Gorst-Rasmussen. DA Lane et al. Assessment of the CHA2DS2-VASc score in predicting ischemic stroke, thromboembolism, and death in patients with heart failure with and without atrial fibrillation. Jama. 2015;314:1030-8.

9. Biancari F, MA Asim Mahar, OP Kangasniemi. CHADS2 and CHA2DS2- VASc scores for prediction of immediate and late stroke after coronary artery bypass graft surgery. J Stroke Cerebrovasc Dis. 2013;22:1304-11.

10. Mitchell LB, DA Southern, D Galbraith, et al. Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores. Heart. 2014;100:1524-30.

11. Balci KG, O Maden, MM Balci, et al. Relation Between TRCA complication rates and peak ACT levels stratified according to the BMI tertiles. Angiology. 2018;69:400-5.

12. Burzotta FC, Trani MA, Mazzari et al. Vascular complications and access crossover in 10,676 transradial percutaneous coronary procedures. Am Heart J. 2012;163:230-8.

13. Agostoni P, GG Biondi-Zoccai, ML de Benedictis, et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol. 2004;44:349-56.

14. Louvard Y, T Lefevre, A Allain, et al. Coronary angiography through the radial or the femoral approach: The CARAFE study. Catheter Cardiovasc Interv. 2001;52:181-7.

15. Mattea V, C Salomon, N Menck, et al. Low rate of access site complications after transradial coronary catheterization: A prospective ultrasound study. Int J Cardiol Heart Vasc. 2017;14:46-52.

16. Camm AJ, GY Lip, R De Caterina, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. Europace. 2012;14:1385-413.

17. Trantalis G, K Aggeli, K Toutouzas, et al. The prognostic value of CHA2DS2-VASc and GRACE risk scores in patients with ACS. Hellenic J Cardiol, 2018.

18. Mirbolouk F, M Gholipour, A Salari, et al. CHA2DS2-VASc score predict no-reflow phenomenon in primary percutaneous coronary intervention in primary percutaneous coronary intervention. J Cardiovasc Thorac Res. 2018;10:46-52.

19. Kurtul A. Usefulness of the CHA2DS2-VASc score in predicting in-stent restenosis among patients undergoing revascularization with bare-metal stents. Clin Appl Thromb Hemost. 2018;24:589-95.

20. Unal S, B Acar, C Yayla, et al. Importance and usage of the CHA2DS2- VASc score in predicting acute stent thrombosis. Coron Artery Dis. 2016; 27:478-82.

21. Ipek G, T Onuk, MB Karatas, et al. CHA2DS2-VASc score is a predictor of no-reflow in patients with st-segment elevation myocardial infarction who underwent primary percutaneous intervention. Angiology. 2016;67:840-5.

22. Chan YH, KH Yiu, KK Lau, et al. The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation. Atherosclerosis. 2014;237:504-13.

23. Iwakura K, H Ito, M Ikushima, et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol. 2003;41:1-7.

24. Di Carli MF, J Janisse, G Grunberger, et al. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol. 2003;41:1387-93.

25. Dean J, SD Cruz, PK Mehta, et al. Coronary microvascular dysfunction: sex-specific risk, diagnosis, and therapy. Nat Rev Cardiol. 2015;12:406-14.

26. Crea F, PG Camici, CN Bairey Merz. Coronary microvascular dysfunction: an update. Eur Heart J. 2014;35:1101-11.

27. Badr S, H Kitabata, R Torguson, et al. Incidence and correlates in the development of iatrogenic femoral pseudoaneurysm after percutaneous coronary interventions. J Interv Cardiol. 2014;27:212-6.

28. Sanmartin M, D Cuevas, J Goicolea, et al. Vascular complications associated with radial artery access for cardiac catheterization. Rev Esp Cardiol. 2004;57:581-4.

29. Ge J. R Erbel, HJ Rupprecht, et al. Comparison of intravascular ultrasound and angiography in the assessment of myocardial bridging. Circulation. 1994;89:1725-32.

30. Ge J, R Erbel, G Gorge, et al. High wall shear stress proximal to myocardial bridging and atherosclerosis: intracoronary ultrasound and pressure measurements. Br Heart J. 1995;73:462-5.

31. Wilk G, G Osmenda, P Matusik, et al. Endothelial function assessment in atherosclerosis: comparison of brachial artery flow‑mediated vasodilation and peripheral arterial tonometry. Polish Arc Int Med. 2013;123:443-52.

32. Duca L, S Blaise, B Romier, et al. Matrix ageing and vascular impacts: focus on elastin fragmentation. Cardiovas res. 2016;110:298-308.

33. Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation. 2003;107:490-7.
Medicine Science-Cover
  • ISSN: 2147-0634
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 2012
  • Yayıncı: Effect Publishing Agency ( EPA )